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Introduction: There is a widely held view that vein grafts for infrainguinal arterial reconstruction perform much better 
than prosthetic conduits, the best of which seems to be PTFE. Many randomised studies have been conducted which 
confirm this opinion, but is the difference as large as it is thought o be? One interesting feature of published trials is 
that the results for obligatory PTFE (when no vein is available) were much worse than the results for randomised PTFE 
grafts. The only way to explain this is that these groups of patients were not similar, and there are probably other factors 
which contribute to the difference in results when vein and PTFE grafts are compared. 
Materials and Method: A consecutive series of 109 femoro-infrapopliteal grafts undertaken for critical limb ischaemia 
was analysed to see the difference between vein and PTFE with vein cuff grafts. 
Results: Vein grafts were superior to PTFE grafts when the whole cohort was included (p = 0.0038); however, there was 
no significant difference when the patients were stratified for inflow and runoff status. 
Conclusions: The difference between vein and PTFE has probably been exaggerated in the past, due to differences in 
risk factors and in the extent of arterial disease between the two groups of patients. The advantage of vein becomes more 
significant with time. 
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Introduction 
Critical limb ischaemia (CLI) is often the result of 
multilevel arterial occlusion, which requires the in- 
sertion of a long graft from the femoral artery to the 
crural or pedal vessels in order to save the foot. 
Autologous aphenous vein provides the best available 
conduit for infrapopliteal reconstructionS'2; however, 
in a large proportion of patients these veins may be 
unavailable or inadequate. 2 This problem has en- 
couraged the development ofseveral types of synthetic 
grafts, of which polytetrafluoroethylene (PTFE) is the 
most widely used, with acceptable mid-term patency 
rates. 2~ 
Michaels, 7in his excellent review article, performed 
a meta-analysis of approximately 40 publications of 
femoropopliteal grafts in order to establish whether 
vein or prosthetic material was superior. He showed 
that the differences in occlusion rate between vein and 
prosthetic grafts in the first year were related to the 
length of the graft, being smallest for above-knee 
grafts and greatest for distal grafts. He concluded that 
* Address all correspondence to: P. R. Taylor. 
saphenous vein was the first choice for all infrainguinal 
bypass surgery. However, he suggested that the ad- 
vantages of vein were overestimated. 
In a well designed multicentre prospective ran- 
domised trial, Veith et al. 2 reported a primary patency 
rate of 29% at 3 years (12% at 4 years) for femorocrural 
PTFE grafts, which was low compared with the 50% 
primary patency rate observed for vein grafts at 3 
years. There was also a further group of patients, 
who were unsuitable for randomisation, who had 
obligatory PTFE grafts. There were some interesting 
observations in this study which deserve further con- 
sideration. Firstly, the results for obligatory PTFE 
femorocrural grafts were considerably worse than 
those for randomised PTFE grafts. Primary patency at 
3 years for randomised grafts was 29% at 3 years, 
compared with 18% for obligatory grafts. Secondly, 
this was also true for obligatory infragenicular (crural 
and popliteal) PTFE grafts, which showed patency 
rates of 47% for randomised compared with 29% for 
obligatory grafts at 4 years. Thirdly, there was no 
significant difference between randomised vein and 
PTFE grafts to the popliteal artery (p>0.25). Fur- 
thermore, there was no significant difference in limb 
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salvage between randomised vein and PTFE grafts 
(61% vs. 57% at 4 years). 
Despite the initial enthusiasm based on good results 
for PTFE grafts to proximal outflow sites such as 
the above-knee (AK) or below-knee (BK) popliteal 
arteries, 2'6 the discouraging results of PTFE when used 
for femorotlbial grafts 5'8-11 has compelled many sur- 
geons to use vein in all cases of infrapopliteal re- 
construction. 13 Some authors have recommended the 
use of other vein sources, such as short saphenous, 
arm or deep veins, ~3 in order to avoid prosthetic ma- 
terial, while others suggest hat primary amputation 
should be performed when autologous vein is un- 
available. 9;~4'15 However, patency rates for veins other 
than long saphenous vein (LSV) are initially good, but 
are inferior to those of LSV in the long-term. 16 The 
patency at 3-5 years for non-LSV vein grafts is similar 
to the best results reported for PTFE with vein cuff or 
patch 17'18 or composite grafts. .9 Abbot 16 reports a 3-year 
patency of 40% for alternate vein grafts, compared to 
60% for LSV grafts. Taylor et al. 2° report 5-year sec- 
ondary patency for PTFE grafts with vein patch, which 
varies from 77% (for AK grafts) to 54% for infra- 
popliteal grafts. 
There are series which have shown good patency 
rates for femorotibial PTFE grafts, which are com- 
parable to those for vein. 17'18'2° Recently established 
techniques using vein patches 12'17 or cuffs ~8 for the 
distal anatomosis of femoro-below-knee popliteal and 
femorodistal PTFE grafts and the use of intense sur- 
veillance programmes have improved results. 21 The 
role of an adjuvant arteriovenous fistula is less clear. 22 
Some vascular surgeons reject PTFE even for short 
grafts to the above-knee popliteal artery, 23 a site for 
which comparable results have been shown for both 
vein and prosthetic grafts. 2'5'5-7 
The problem of which conduit should be used for 
secondary revascularisation when the original infra- 
guinal bypass has failed is pertinent. In a recent 
report, 13 secondary autogenous vein other than LSV 
when used for infraguinal bypass showed a 35% 5- 
year primary patency rate. 
Even LSV grafts used for secondary procedures 
following early failure (within 3 months) of the original 
graft showed a discouraging primary patency rate of 
27% at 5 years, compared to 25% for prosthetic grafts. 
These results are difficult to explain (poor quality of 
vein compromised runoff may be responsible), but 
confirm the differences observed by Veith et al. 2 There 
are several reasons why patients with aggressive 
atherosclerosis should have poor quality or absent 
LSV, including poor flow through diseased arteries, 
sedentary life style enforced by elaudication or angina, 
and ischaemic heart disease for which coronary bypass 
saphenous vein grafts have been inserted. Since ob- 
ligatory PTFE grafts are performed in high risk cir- 
cumstances, usually as secondary procedures, it may 
not be fair to compare these with vein grafts, most of 
which are inserted as primary procedures. Fur- 
thermore, vein grafts are often undertaken for dis- 
abling claudicatlon, an indication which is associated 
with a considerably better outcome compared with 
CLI. 11 
Differentiation of infrapopliteal PTFE grafts under- 
taken for CLI in primary and secondary re- 
vascularisation procedures may identify two different 
populations of patients. Schweiger et al. 24 reported 
primary patency rates of 42% at 4 years for primary 
femorotibial PTFE grafts, compared to 14% for sec- 
ondary procedures. The incidence of risk factors was 
higher in the secondary group and they also had poor 
distal runoff. Christenson et al. 6 showed that secondary 
patency for infragenicular PTFE grafts undertaken for 
critical limb ischaemia varied from 55% at 6 years for 
limbs with two to three patent calf vessels to 25% for 
limbs in which a single or no calf vessel was patent. 
In most reports comparing vein to PTFE grafts, the 
proportion of secondary procedures i not stated, and 
if it is may vary from 7% 6 to 71%. 5 Therefore, the 
results should be cautiously interpreted and the nega- 
tive view of PTFE grafts may thus be unfairly biased. 
From the authors' experience with femorocrural 
arterial reconstruction undertaken for CLI, it could 
easily be deduced that PTFE (Irnpra, U.K.) grafts are 
not worthwhile, as they were associated with a dismal 
23% secondary patency at 3 years, compared with 55% 
for vein grafts. 25 A vein cuff at the distal anastomotic 
site was used for all PTFE grafts. However, further 
analysis howed that 67% of PTFE grafts were under- 
taken as secondary procedures, compared to 35% of 
vein grafts. Furthermore, 62% of the PTFE grafts had 
poor outflow (judged by impaired pedal vessels and 
no calf vessel crossing the ankle) compared with 36% 
of vein grafts. 
Based on the factors that were shown to affect the 
outcome, we developed a scoring system which could 
differentiate the patients into three groups: those with 
a poor, a moderate or an excellent inflow and runoff 
conditions (based on the number and quality of patent 
calf and pedal vessels and the number of vessels 
crossing the ankle). 26 Comparison of PTFE with vein 
grafts for each group (using the Log rank test), showed 
no statistical significance in secondary patency (Table 
1, Figs 1-3). Vein and PTFE grafts seemed to perform 
equally well in good conditions (p = 0.7100) and both 
did poorly when inflow and runoff were compromised 
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Table 1. CompariSon of vein and PTFE grafts in the three groups of patients. Despite the fact that there was no significant difference 
in each individual group, overall vein grafts were shown to have a better statistically significant outcome. 
Total Number of events Number censored Percent censored Secondary patency Significance 
Poor status 
All 35 27 
PTFE 23 17 
Vein 12 10 
Moderate status 
All 46 18 
PTFE 21 10 
Vein 25 8 
Good status 
All 28 4 
PTFE 5 1 
Vein 23 3 
Overall 109 49 
8 22.86 p =0.6850 
6 26.09 0% 
2 16.67 0% 
28 60.87 p = 0.4253 
11 52.38 30% 
17 68.00 61% 
24 85.71 p = 0.7100 
4 80.00 75% 
20 86.96 83% 
60 55.05 45% p = 0.0038 
Vein vs. PTFE in poor inflow and runoff conditions 
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Fig. 1. Comparison of vein and PTFE femorocrural grafts in limbs 
with compromised inflow and outflow conditions. All of them failed 
in 9 months, irrespective of the type of conduit. 
(---) Vein: SP=0%, SE= 10.08. (--) PTFE: SP=0%, SE=8.83. 
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Fig. 2. Comparison in the intermediate group of patients. Despite 
the trend for vein grafts to perform better, no statistical significance 
was shown. 
(---) Vein: SP=61%, SE=9.43. (--) PTFE: SP=30%, SE=9.72. 
(p = 0.6850). There was a trend for vein grafts to per- 
form better in the intermediate group, but this was 
not shown to be statistically significant (p = 0.4253). In 
contrast, when vein and PTFE grafts were compared 
as independent variables, the overall difference was 
significant (p = 0.0038), with PTFE grafts performing 
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Fig. 3. Secondary patency of vein and PTFE grafts in limbs with 
good inflow and excellent runoff. 
(---) Vein: SP=82%, SE=9.6. (--) PTFE: SP=75%, SE=21.65. 
less well .  However ,  the numbers  in some groups  were  
smal l  and the length of the s tudy  re lat ive ly  short,  
a l though the s tandard  error  was  a lmost  a lways  be low 
10 (8.17 for ve in  and  8.11 for PTFE). 
One shou ld  not  ext rapo late  f rom this observat ion  
and deduce  that there is no di f ference between ve in  
and  PTFE grafts, as c lear ly there is. However ,  the 
di f ference is not  as dramat ic  as prev ious ly  bel ieved.  
One reason may be the usage of poor  qual i ty  veins, 
as it has been shown that ve ins w i th  a d iameter  less 
than 3.5 mm and impa i red  compl iance are more  l ikely 
to occ lude or deve lop  stenosesa7; however ,  the main  
reason is p robab ly  the poor  strat i f icat ion of pat ient  
r isk factors, and  the extent of arter ial  d isease in studies 
which  compare  ve in  w i th  PTFE. The longer  the study,  
the more  the advantage  of venous  condui ts  becomes 
evident.  2This has been shown in many reports  of both  
randomised  and  non- randomised  series. Patency  rates 
remain  s imi lar  for the first 12-24 months  and  d iverge 
thereafter,  eaching statist ical s ignif icance at 2-3 years,  
wh ich  becomes more  impor tant  after 6 years.  24"8'28 
The di f ference is less s ignif icant when grafts to more  
prox imal  out f low sites are compared .  2~-7 This cou ld  
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be attr ibuted to the fact that PTFE patency may be 
more dependent  on outf low resistance and less tolerant 
to low flow states, which is probably  the reason why  
some may occlude wi thout  the presence of a stenotic 
lesion. 29 
Patients present ing wi th  CLI usual ly  have  a lower 
survival  rate compared with  claudicants, and therefore 
the use of PTFE grafts for treat ing CLI when no ve in  
is avai lable is probably  justified, part icular ly when 
used with  ve in  cuffs or patches. 17"18'2° A case can also be 
made for use of prosthetic material  for more proximal  
grafts in poor  risk pat ients wi th  less than 2-3 years'  
life expectancy. There may be other possible reasons 
for us ing prostheses in preference to vein. The value 
of preserv ing the ve in  for later surgery requires careful 
mathemat ica l  evaluat ion,  which was done by Michaels 
in 1989. 7Shorter operat ing time, fewer compl icat ions 
or shorter hospital  stay may be other advantages,  
part icular ly for above-knee femoropopl i teal  grafts. 
This pol icy is supported by similar l imb salvage rates 
in pat ients wi th  inf raguinal  or infrapopl i teal  grafts 
that have been observed with  both types of conduits.  2'
5,18,19,24 
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